Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

4.40
Delayed Data
As of Mar 24
 -0.07 / -1.57%
Today’s Change
2.65
Today|||52-Week Range
8.00
+55.48%
Year-to-Date
Company News for March 20, 2017
Mar 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.47
Today’s open4.45
Day’s range4.28 - 4.45
Volume92,779
Average volume (3 months)89,095
Market cap$36.6M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+70.12%
Earnings growth (this year)+37.07%
Earnings growth (next 5 years)+42.90%
Revenue growth (last year)+56.90%
P/E ratioNM
Price/Sales0.53
Price/Book7.39

Competitors

 Today’s
change
Today’s
% change
APVOAptevo Therapeutics ...-0.03-1.62%
HSGXHistogenics Corp+0.01+0.60%
COOLPolarityte Inc+0.12+1.43%
CSBRChampions Oncology I...-0.00-0.00%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$35.3M
Annual profit (last year)-$32.7M
Net profit margin-92.55%

Profile

Sector
Distribution Services
Industry
Wholesale Distributors
Chief Executive Officer &
Director
David J. Mazzo
Chief Financial Officer &
Senior Vice President
Joseph Talamo
Corporate headquarters
Basking Ridge, New Jersey

Forecasts


Search for Jobs